Medicare Enrolled
Dr. Martin Gordon, M.D.
Pulmonary Disease · Beverly Hills, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gordon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gordon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gordon
Dr. Martin Gordon is a pulmonary disease specialist in Beverly Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gordon performed 5,057 Medicare services across 2,679 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gordon received a total of $9,806 from 44 pharmaceutical and/or device companies across 442 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gordon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in CA
$9,806 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,057
Medicare services
Top 5% in CA for pulmonary disease
2,679
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~266 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,524 | $134 | $369 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,037 | $94 | $125 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
564 | $25 | $148 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
484 | $11 | $147 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
457 | $3 | $20 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
301 | $134 | $200 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
144 | $169 | $275 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
134 | $136 | $250 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
91 | $35 | $148 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
60 | $4 | $25 |
| New patient office visit, complex (60-74 min) | 54 | $168 | $581 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
34 | $33 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $97 | $300 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
27 | $28 | $250 |
| Chest X-ray, 1 view An X-ray image of the chest taken from a single angle. This imaging test is used to visualize the structures within the chest cavity. |
26 | $21 | $123 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
24 | $10 | $30 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
20 | $10 | $95 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $103 | $200 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
15 | $17 | $97 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $44 | $195 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,806
Total received (2018-2024)
Avg $1,401/year across 7 years
Top 17% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
442
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,806 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,367
2023
$1,096
2022
$1,344
2021
$1,146
2020
$1,255
2019
$1,753
2018
$1,844
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$391
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$256
Novartis Pharmaceuticals Corporation
$125
Gilead Sciences, Inc.
$116
ANI Pharmaceuticals, Inc.
$93
Mylan Specialty L.P.
$77
Insmed, Inc.
$64
Exact Sciences Corporation
$53
Amgen Inc.
$39
Electromed, Inc.
$35
GlaxoSmithKline, LLC.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Hikma Pharmaceuticals USA
$23
Azurity Pharmaceuticals, Inc.
$19
IDORSIA PHARMACEUTICALS US INC
$16
Top 3 companies account for 56.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,948
GlaxoSmithKline, LLC.
$1,153
Amgen Inc.
$874
Mallinckrodt Hospital Products Inc.
$721
Boehringer Ingelheim Pharmaceuticals, Inc.
$562
Merck Sharp & Dohme Corporation
$437
Novartis Pharmaceuticals Corporation
$377
Mylan Specialty L.P.
$347
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$256
Mallinckrodt LLC
$252
Mallinckrodt Enterprises LLC
$222
Genentech USA, Inc.
$208
IDORSIA PHARMACEUTICALS US INC
$189
Advanced Respiratory, Inc
$170
ARBOR PHARMACEUTICALS, INC.
$163
ADVANCED RESPIRATORY, INC
$149
Gilead Sciences, Inc.
$147
ANI Pharmaceuticals, Inc.
$143
Lilly USA, LLC
$139
AbbVie Inc.
$124
Philips Electronics North America Corporation
$115
PFIZER INC.
$105
Circassia Pharmaceuticals Inc
$92
AbbVie, Inc.
$87
Regeneron Healthcare Solutions, Inc.
$83
Paratek Pharmaceuticals, Inc.
$78
Electromed, Inc.
$71
GENZYME CORPORATION
$68
Insmed, Inc.
$64
ABBVIE INC.
$62
Exact Sciences Corporation
$53
Nabriva Therapeutics, plc
$50
Amarin Pharma Inc.
$39
Allergan, Inc.
$39
Teva Pharmaceuticals USA, Inc.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$27
Hikma Pharmaceuticals USA
$23
E.R. Squibb & Sons, L.L.C.
$22
Biohaven Pharmaceuticals, Inc.
$21
Sunovion Pharmaceuticals Inc.
$21
Grifols USA, LLC
$20
Azurity Pharmaceuticals, Inc.
$19
IBSA Pharma Inc.
$19
Alexion Pharmaceuticals, Inc.
$18
Top 3 companies account for 40.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · ADVAIR · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · DUAKLIR PRESSAIR · DUPIXENT · Dymista · ELIQUIS · EMGALITY · ENTRESTO · Edarbi · Edarbyclor · FASENRA · GLASSIA · HORIZANT · JANUVIA · LEQVIO · LINZESS · MOUNJARO · NUCALA · NURTEC ODT · NUZYRA · OFEV · Otezla · PNEUMOVAX 23 · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C Liquid · Prolia · QUVIVIQ · QVAR · Repatha · Ryaltris · SIVEXTRO · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Synthroid · TAGRISSO · TEZSPIRE · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · Tirosint · UBRELVY · Utibron · Vascepa · XIFAXAN · XOLAIR · Xenleta · Xofluza · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
253
Per 100K population
2.6
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gordon is a clinical cardiology specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement in the top 17% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gordon experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Gordon performed 1,524 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gordon receive payments from pharmaceutical companies?
Yes. Dr. Gordon received a total of $9,806 from 44 companies across 442 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gordon's costs compare to other pulmonary diseases in Beverly Hills?
Dr. Gordon's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gordon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Beverly Hills
Browse pulmonary diseases in Beverly Hills ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in CA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in CA
Which CA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology